Elizabeth Wood co-founded and co-runs JURA Bio, Inc., an early-stage therapeutics start up focusing on developing and delivering cell-based therapies for the treatment of autoimmune and immune-related neurodegenerative disease. Before JURA, Wood was a post-doc in the lab of Adam Cohen at Harvard Department of Chemistry and Physics. She began her PhD with Angela Belcher and Markus Buehler at MIT, and finished it under the supervision of Claus Helix-Nielsen at The Technical University of Denmark, Departments of Physics and Civil and Environmental Engineering.
She has also worked at the University of Copenhagen’s Biocenter with Kresten Lindorff-Larsen, integrating computational methods with experimental studies to understand how the ability of proteins to change their shape help modulate their function. Wood is a visiting scientist at the Broad Institute, where she serves on the steering committee of the Machine Inference Algorithm’s Initiative and as the primary organizer of the NeurIPS Workshop Learning Meaningful Representations of Life. She currently serves on the board of Pure Home Water.